Apogee Therapeutics, Inc. (APGE) Operating income 2023–2025
Apogee Therapeutics, Inc. (APGE) annual operating income history from SEC filings — each fiscal year as reported.
-$285.6MFY2025 · since FY2023: -$93.0M → -$285.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$285.6M | -31.7% |
| FY2024 | -$216.9M | -133.2% |
| FY2023 | -$93.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice